Brian Skorney
Stock Analyst at Robert W. Baird
(0.12)
# 4,482
Out of 4,574 analysts
851
Total ratings
37.2%
Success rate
-5.6%
Average return
Main Sectors:
Stocks Rated by Brian Skorney
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintained: Sell | $320 → $350 | $477.36 | -26.68% | 59 | Jul 7, 2026 | |
| RGNX REGENXBIO | Maintained: Buy | $27 → $32 | $9.73 | +228.88% | 18 | Jun 23, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $433 → $400 | $325.30 | +22.96% | 3 | Jun 2, 2026 | |
| ANRO Alto Neuroscience | Maintained: Buy | $38 → $36 | $26.78 | +34.43% | 15 | May 18, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $112 → $129 | $113.03 | +14.13% | 43 | May 7, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $209 → $252 | $253.87 | -0.74% | 2 | May 6, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $241 → $246 | $241.00 | +2.07% | 3 | May 5, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $63 → $97 | $65.42 | +48.27% | 6 | Mar 9, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Hold | $22 → $20 | $15.68 | +27.55% | 108 | Feb 26, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $108 → $145 | $129.31 | +12.13% | 81 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $637 → $742 | $656.01 | +13.11% | 63 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $250 | $202.19 | +23.65% | 97 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $83.73 | -25.95% | 16 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 → $52 | $14.32 | +263.13% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $186 | $175.77 | +5.82% | 52 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $32 | $24.44 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $28.00 | n/a | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $11.47 | n/a | 1 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $20 | $12.78 | n/a | 37 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $4.66 | n/a | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.38 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $215 | $376.04 | n/a | 51 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $23.38 | n/a | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $30 | $4.12 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $0.2264 | n/a | 14 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $32.12 | n/a | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $16.86 | n/a | 24 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $39.41 | n/a | 16 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $25.55 | n/a | 14 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $15.15 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $7.13 | n/a | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 | $2.84 | n/a | 6 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 → $146 | $10.73 | n/a | 5 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $3.10 | n/a | 11 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $4.89 | n/a | 8 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $144 | $54.15 | n/a | 1 | Mar 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $83 → $138 | $325.90 | n/a | 5 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $42 | $106.92 | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $59.33 | n/a | 11 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $13 | $21.44 | n/a | 7 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.04 | n/a | 3 | Jan 22, 2015 |
Vertex Pharmaceuticals
Jul 7, 2026
Maintained: Sell
Price Target: $320 → $350
Current: $477.36
Upside: -26.68%
REGENXBIO
Jun 23, 2026
Maintained: Buy
Price Target: $27 → $32
Current: $9.73
Upside: +228.88%
Praxis Precision Medicines
Jun 2, 2026
Maintained: Buy
Price Target: $433 → $400
Current: $325.30
Upside: +22.96%
Alto Neuroscience
May 18, 2026
Maintained: Buy
Price Target: $38 → $36
Current: $26.78
Upside: +34.43%
Mirum Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $112 → $129
Current: $113.03
Upside: +14.13%
Jazz Pharmaceuticals
May 6, 2026
Maintained: Buy
Price Target: $209 → $252
Current: $253.87
Upside: -0.74%
Axsome Therapeutics
May 5, 2026
Maintained: Buy
Price Target: $241 → $246
Current: $241.00
Upside: +2.07%
Xenon Pharmaceuticals
Mar 9, 2026
Maintained: Buy
Price Target: $63 → $97
Current: $65.42
Upside: +48.27%
Sarepta Therapeutics
Feb 26, 2026
Maintained: Hold
Price Target: $22 → $20
Current: $15.68
Upside: +27.55%
Gilead Sciences
Feb 11, 2026
Maintained: Hold
Price Target: $108 → $145
Current: $129.31
Upside: +12.13%
Feb 2, 2026
Maintained: Hold
Price Target: $637 → $742
Current: $656.01
Upside: +13.11%
Oct 31, 2025
Maintained: Buy
Price Target: $255 → $250
Current: $202.19
Upside: +23.65%
Sep 26, 2025
Maintained: Buy
Price Target: $62
Current: $83.73
Upside: -25.95%
Aug 12, 2025
Maintained: Buy
Price Target: $57 → $52
Current: $14.32
Upside: +263.13%
Jul 31, 2025
Maintained: Buy
Price Target: $180 → $186
Current: $175.77
Upside: +5.82%
Jun 18, 2025
Maintained: Buy
Price Target: $46 → $32
Current: $24.44
Upside: n/a
Feb 7, 2025
Maintained: Buy
Price Target: $25 → $17
Current: $28.00
Upside: n/a
Dec 12, 2024
Initiated Coverage: Buy
Price Target: $30
Current: $11.47
Upside: n/a
Nov 26, 2024
Maintained: Buy
Price Target: $26 → $20
Current: $12.78
Upside: n/a
Nov 20, 2024
Maintained: Buy
Price Target: $28
Current: $4.66
Upside: n/a
Nov 6, 2024
Maintained: Hold
Price Target: $4
Current: $4.38
Upside: n/a
Sep 24, 2024
Rated: Sell
Price Target: $215
Current: $376.04
Upside: n/a
Sep 5, 2024
Initiated Coverage: Buy
Price Target: $26
Current: $23.38
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $28 → $30
Current: $4.12
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $7.5
Current: $0.2264
Upside: n/a
Nov 10, 2022
Maintained: Buy
Price Target: $28
Current: $32.12
Upside: n/a
Nov 7, 2022
Maintained: Hold
Price Target: $8
Current: $16.86
Upside: n/a
Sep 8, 2022
Maintained: Hold
Price Target: $6
Current: $39.41
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $15
Current: $25.55
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $16
Current: $15.15
Upside: n/a
Aug 12, 2021
Initiated Coverage: Buy
Price Target: $34
Current: $7.13
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $39
Current: $2.84
Upside: n/a
Aug 5, 2021
Maintained: Hold
Price Target: $85 → $146
Current: $10.73
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: $6
Current: $3.10
Upside: n/a
Nov 1, 2018
Maintained: Buy
Price Target: $7 → $3
Current: $4.89
Upside: n/a
Mar 27, 2018
Maintained: Buy
Price Target: $144
Current: $54.15
Upside: n/a
Feb 28, 2018
Reiterated: Hold
Price Target: $83 → $138
Current: $325.90
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $32 → $42
Current: $106.92
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $115
Current: $59.33
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $14 → $13
Current: $21.44
Upside: n/a
Jan 22, 2015
Reiterated: Buy
Price Target: $11
Current: $4.04
Upside: n/a